FDA clears DeFloria’s cannabis-based autism treatment for phase 2 trial

Green Market Report
By Adam JacksonFeb 24, 2025, 9:56 am134 ptsTrendingTop
DeFloria said Monday that the Federal Drug Administration has stamped the firm’s application to begin a Phase 2 clinical trial for AJA001, an oral cannabinoid drug being made to treat symptoms of autism spectrum disorder. The company, which was formed in 2023 as a joint-venture among Charlotte’s Web (OTCQX:…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Cannabis MSO Jushi benefiting from little-used IRS tax-credit program 68

Canada reaches half a billion in monthly cannabis sales in December 2024 68

Indiana Cannabis Legalization Bill Fails to Advance 67

Using The Marijuana Components THC-V And CBD Every Day Helps People Lose Weight, Study Finds 66

Dozens Of New Jersey Marijuana Businesses Push To Legalize Home Cultivation, Despite Resistance From Governor And Legislative Leaders 64

4 Tips for Smooth Cultivation Facility Compliance Inspections 63

New Jersey Has $6M+ In Unspent Social Equity Tax Funds 63

Bulk Cannabis Packaging Auction Opens for Bidding 63

About NewsBudz

NewsBudz is a marijuana and medical cannabis news app. The site delivers a daily feed of the latest cannabis news. We aggregate over 30 of the web's best sources for news about marijuana, hemp and legalization to keep you informed.

Stay on top of the latest news headlines, trends and developments worldwide around recreational and medical marijuana. Sit back and relax, while you read learn and share. On the web or your mobile device, NewsBudz is your cannabis news stream.